Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers
In adjusted analyses, systemic beta-blocker use was not significantly associated with the risk of progression from iAMD to advanced NV or NNV AMD.
Authors
- Anne Strong Caldwell (ORCID: https://orcid.org/0000-0001-6017-8722)
- Alan G. Palestine (ORCID: https://orcid.org/0000-0001-6361-6767)
- A. Itzam Marin
- Zafar Gill (ORCID: https://orcid.org/0000-0001-7679-6349)
- Naresh Mandava (ORCID: https://orcid.org/0000-0003-3251-6469)
- Talisa E. de Carlo (ORCID: https://orcid.org/0000-0001-7289-1509)
- Talisa E. de Carlo (ORCID: https://orcid.org/0000-0002-3264-8982)
- Jennifer L. Patnaik (ORCID: https://orcid.org/0000-0002-0375-0187)
- Benedikt Hogan (ORCID: https://orcid.org/0000-0003-0853-4755)
- Anne M. Lynch (ORCID: https://orcid.org/0000-0001-6508-8136)
- Niranjan Manoharan (ORCID: https://orcid.org/0000-0001-5746-6854)
- Nihaal Mehta
- Andres Liske-Cervantes
Institutions
- University of Colorado Denver (US)
Publication Details
- Journal
- Frontiers in Ophthalmology
- Published
- 2025-04-14
- DOI
- https://doi.org/10.3389/fopht.2025.1535791
- Citations
- 2
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.41
Funders
- Research to Prevent Blindness
- National Institutes of Health